Application of a derivative of human defensin 5 to treat ionizing radiation-induced enterogenic infection

Gaomei Zhao,Yingjuan He,Yin Chen,Yiyi Jiang,Chenwenya Li,Tainong Xiong,Songling Han,Yongwu He,Jining Gao,Yongping Su,Junping Wang,Cheng Wang

DOI: https://doi.org/10.1093/jrr/rrad104

2024-01-23

Journal of Radiation Research

Abstract:Abstract Enterogenic infection is a common complication for patients with radiation injury and requires efficient therapeutics in the clinic. Herein, we evaluated the promising drug candidate T7E21RHD5, which is a peptide derived from intestinal Paneth cell-secreted human defensin 5. Oral administration of this peptide alleviated the diarrhea symptoms of mice that received total abdominal irradiation (TAI, γ-ray, 12 Gy) and improved survival. Pathologic analysis revealed that T7E21RHD5 elicited an obvious mitigation of ionizing radiation (IR)-induced epithelial damage and ameliorated the reduction in the levels of claudin, zonula occluden 1 and occludin, three tight junction proteins in the ileum. Additionally, T7E21RHD5 regulated the gut microbiota in TAI mice by remodeling β diversity, manifested as a reversal of the inverted proportion of Bacteroidota to Firmicutes caused by IR. T7E21RHD5 treatment also decreased the abundance of pathogenic Escherichia–Shigella but significantly increased the levels of Alloprevotella and Prevotellaceae_NK3B31, two short-chain fatty acid-producing bacterial genera in the gut. Accordingly, the translocation of enterobacteria and lipopolysaccharide to the blood, as well as the infectious inflammatory responses in the intestine after TAI, was all suppressed by T7E21RHD5 administration. Hence, this versatile antimicrobial peptide possesses promising application prospects in the treatment of IR-induced enterogenic infection.

oncology,radiology, nuclear medicine & medical imaging,biology

What problem does this paper attempt to address?

This paper aims to solve the problem of intestinal infections caused by radiation. Specifically, the research team evaluated the application potential of a peptide T7E21RHD5 derived from human defensin 5 (HD5) in the treatment of radiation - induced intestinal infections. Through mouse model experiments, the paper explored the protective effects of T7E21RHD5 on mice after total abdominal irradiation (TAI), including the effects of alleviating diarrhea symptoms, increasing survival rate, relieving intestinal mucosal damage, reducing endotoxemia, and regulating the intestinal microbiota.

### Main research questions:
1. **The effect of T7E21RHD5 on the survival rate of mice after TAI**: The study found that T7E21RHD5 can significantly increase the survival rate of mice after TAI.
2. **The alleviation of diarrhea symptoms in mice after TAI by T7E21RHD5**: T7E21RHD5 can significantly relieve the diarrhea symptoms of mice after TAI.
3. **The alleviation of intestinal mucosal damage in mice after TAI by T7E21RHD5**: Through pathological analysis, the study found that T7E21RHD5 can significantly relieve the intestinal mucosal damage caused by TAI, including maintaining the height of intestinal villi and the number of crypts, and increasing the number of goblet cells.
4. **The improvement of the expression of intestinal tight junction proteins in mice after TAI by T7E21RHD5**: T7E21RHD5 can significantly improve the decreased expression of tight junction proteins (such as occludin, claudin, and zonula occluden1) caused by TAI.
5. **The inhibition of intestinal infections in mice after TAI by T7E21RHD5**: T7E21RHD5 can significantly reduce the level of endotoxin (LPS) in the blood of mice after TAI, reduce the incidence of bacteremia, and reduce the inflammatory response.
6. **The regulation of the intestinal microbiota in mice after TAI by T7E21RHD5**: T7E21RHD5 can significantly regulate the intestinal microbiota of mice after TAI, reverse the microbiota dysbiosis caused by radiation, especially increase the number of beneficial bacteria (such as Alloprevotella and Prevotellaceae), and reduce the number of pathogenic bacteria (such as Escherichia - Shigella).

### Conclusion:
As a rationally designed molecule based on human intestinal defensins, T7E21RHD5 shows application prospects in the treatment of radiation - induced damage. Administration of T7E21RHD5 can alleviate intestinal mucosal damage caused by radiation, reduce the transfer of endogenous bacteria and LPS, thereby alleviating local inflammatory responses and increasing the survival rate of radiation - damaged mice. In addition, T7E21RHD5 can also regulate the intestinal microbiota dysbiosis after radiation by enhancing the abundance of beneficial bacteria, thereby inhibiting intestinal infections. Given the current lack of effective drugs for treating radiation - induced intestinal infections, T7E21RHD5, as a multi - functional antibacterial peptide, is a promising candidate drug.